Evidence map›Paper›PMID 42888454›Full record

ArticleTranslational neurodegeneration2026

ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson's disease.

Zhan Shu, Hoa A Lam, Elizabeth J Videlock, Iris Lindberg, Nigel T Maidment

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Translational neurodegeneration, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhan Shu *Department of Psychiatry and Biobehavioral Sciences, Hatos Center for Neuropharmacology, Semel Institute for Neuroscience and Human Behavior, UCLA School of Medicine, Los Angeles, CA, USA.
Hoa A Lam *Department of Psychiatry and Biobehavioral Sciences, Hatos Center for Neuropharmacology, Semel Institute for Neuroscience and Human Behavior, UCLA School of Medicine, Los Angeles, CA, USA.
Elizabeth J VidelockDivision of Digestive Diseases, Department of Medicine, UCLA School of Medicine, Los Angeles, CA, USA.
Iris LindbergDepartment of Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.
Nigel T MaidmentDepartment of Psychiatry and Biobehavioral Sciences, Hatos Center for Neuropharmacology, Semel Institute for Neuroscience and Human Behavior, UCLA School of Medicine, Los Angeles, CA, USA. nmaidmen@ucla.edu.

Funding

NIH HHS NIA AG062222
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42888454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.